Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We prospectively investigated in hypertensive patients with type 2 diabetes if bedtime treatment with ≥1 hypertension medications exerts better blood pressure control and cardiovascular risk reduction than conventional therapy, in which all medications are ingested in the morning. RESEARCH DESIGN AND METHODS: We conducted a prospective, randomized, open-label, blinded end point trial on 448 hypertensive patients with type 2 diabetes, 255 men/193 women, mean ± SD age 62.5 ± 10.8 years, randomized to ingest all their prescribed hypertension medications upon awakening or ≥1 of them at bedtime. Ambulatory blood pressure was measured for 48 h at baseline and again annually or even more frequently (quarterly) after adjustments in treatment. RESULTS: After a median follow-up of 5.4 years, patients ingesting ≥1 hypertension medications at bedtime showed a significantly lower cardiovascular risk (adjusted by age and sex) than subjects ingesting all medications upon awakening (hazard ratio 0.33 [95% CI 0.21–0.54]; P < 0.001). The difference between groups in the adjusted risk of major events (cardiovascular death, myocardial infarction, and stroke) was also statistically significant (0.25 [0.10–0.61]; P = 0.003). Patients treated at bedtime showed significantly lower sleep time blood pressure mean and higher prevalence of controlled ambulatory blood pressure (62.5 vs. 50.9%; P = 0.013). There was a significant 12% cardiovascular risk reduction per each 5 mmHg decrease in asleep systolic blood pressure during follow-up (P < 0.001). CONCLUSIONS: Among patients with diabetes, treatment with ≥1 hypertension medications at bedtime, compared with all medications upon waking, resulted in improved ambulatory blood pressure control and significantly reduced cardiovascular morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although prior analyses of randomized clinical trials found a benefit to evening versus morning dosing of antihypertensive medications (81,82), these results have not been reproduced in subsequent trials.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [82]
In the citing paper
“Although prior analyses of randomized clinical trials found a bene fi t to evening versus morning dosing of antihypertensive medications (74,75), these results have not been reproduced in subsequent trials.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [75]
In the citing paper
“These results were replicated in people with type II diabetes (181).”
From Role of the circadian system in cardiovascular disease (2018) · cites this paper as [181]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598 · cited 1×
“We thus conclude that the actual controversy on the possible J-shaped relation with CVD risk, described so far only for clinic blood pressure determined in patients presumably treated in the morning (21,22), might not apply (when avoiding nocturnal hypotension) to asleep blood pressure mean, a more significant predict…”
BackgroundDolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227
Ohkubo, T., Hozawa, A., Yamaguchi, J., Kikuya, M., Ohmori, K., Michimata, M., Matsubara, M., Hashimoto, J., Hoshi, H., Araki, T., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200211000-00017 · Cited by 1,053
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study
Boggia, J., Li, Y., Thijs, L., Hansen, T. W., Kikuya, M., Björklund-Bodegård, K., Richart, T., Ohkubo, T., Kuznetsova, T., Torp-Pedersen, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61538-4 · Cited by 887
Fagard, R. H., Celis, H., Thijs, L., Staessen, J. A., Clement, D. L., De Buyzere, M. L., & De Bacquer, D. A. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100727 · Cited by 742
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2010) · Chronobiology International · doi:10.3109/07420528.2010.510230 · Cited by 608 · cited 1×
“The MAPEC (Monitorización Ambulatoria para Predicción de Eventos Cardiovasculares [Ambulatory Blood Pressure Monitoring for Prediction of Cardiovascular Events]) study was specifically designed to investigate prospectively whether bedtime treatment with $1 hypertension medications exerts significantly better blood pre…”
BackgroundSelf-citation
Cited by
Items 101–200 of 213
Current issues in the management and monitoring of hypertension in chronic kidney disease
Garimella, P. S., & Uhlig, K. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328365addf · Cited by 24
White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty
Abolbashari, M. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0964-0 · Cited by 22
Kim, S. Y. H., & Miller, F. G. (2015) · Clinical Trials · doi:10.1177/1740774515607213 · Cited by 18
Smolensky, M. H., Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.05.011 · Cited by 18
Self-citationCircadian Clock Genes in Diabetic Kidney Disease (DKD)
Olaoye, O. A., Masten, S., Mohandas, R., & Gumz, M. L. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1156-z · Cited by 19
Does Timing of Antihypertensive Medication Dosing Matter?
Hermida, R. C., Hermida‐Ayala, R. G., Smolensky, M. H., Mojón, A., Crespo, J. J., Otero, A., Ríos, M. T. P., Domínguez-Sardiña, M., & Fernández, J. R. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01353-7 · Cited by 18
Self-citationSecondary Stroke Prevention: Improving Diagnosis and Management with Newer Technologies
Imam, Y. Z. B., D’Souza, A., Malik, R. A., & Shuaib, A. M. (2016) · Translational Stroke Research · doi:10.1007/s12975-016-0494-2 · Cited by 18
“During follow-up, the risk of development of diabetes was significantly reduced in patients treated with chronotherapy, and in a smaller sub-set of 448 patients with diabetes, there was a significantly lower rate of development of vascular complications [50, 51].”
Murray, M., Dordevic, A. L., Ryan, L., & Bonham, M. P. (2019) · Antioxidants · doi:10.3390/antiox8020049 · Cited by 18
New perspectives on the definition, diagnosis, and treatment of true arterial hypertension
Hermida, R. C., Smolensky, M. H., Mojón, A., Crespo, J. J., Ríos, M. T. P., Domínguez-Sardiña, M., Otero, A., & Fernández, J. R. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1746274 · Cited by 17
“lation [50,81], but those of greater CVD risk, like type 2 diabetes [81,91], CKD [81,92], and resistant hypertension [93].”
BackgroundSelf-citationYu, Y., Li, W., Xu, L., & Wang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124353 · Cited by 21
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2012) · Chronobiology International · doi:10.3109/07420528.2012.702584 · Cited by 16
“…of CVD events than the awake or 24-h BP mean (BenDov et al., 2007; Boggia et al., 2007; Dolan et al., 2005; Fagard et al., 2008; Fan et al., 2010; Hermida et al., 2011c, 2012a, 2013a; Kikuya et al., 2005; Minutolo et al., 2011), a relevant finding also documented for patients with diabetes…”
BackgroundMethodResultInfluentialSelf-citation‘Time and Time Again’: Oscillatory and Longitudinal Time Patterns in Dialysis Patients
Kooman, J. P., Usvyat, L. A., SANDE, F. M. V. D., Thijssen, S., Levin, N. W., Leunissen, K. M. L., & Kotanko, P. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000340022 · Cited by 15
Circadian system and aging: where both times interact
Cobarro, C., Soares, L. I., Kutsenko, Y., & Tomás‐Loba, A. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1646794 · Cited by 16
Epidemiology, Prognosis, and Treatment of Resistant Hypertension
Smith, S. M. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1297 · Cited by 17
Pop, C., Viorel, M., Luchiana, P., Mihaela, C., & Pop, L. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00899-6 · Cited by 16
Recidivism to uncontrolled blood pressure in patients with previously controlled hypertension
Sandhu, A., Ho, P. M., Asche, S. E., Magid, D. J., Margolis, K. L., Sperl‐Hillen, J. M., Rush, B., Price, D. W., Ekstrom, H. L., Tavel, H. M., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.03.012 · Cited by 12
Sindone, A. P., Erlich, J., Lee, C., Newman, H. H., SURANYI, M. G., & Roger, S. D. (2016) · Internal Medicine Journal · doi:10.1111/imj.12975 · Cited by 14
Hermida, R. C., Ayala, D. E., Ríos, M. T. P., Fernández, J. R., Mojón, A., & Smolensky, M. H. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0445-9 · Cited by 11
Self-citationAmbulatory Blood Pressure Monitoring: Recent Evidence and Clinical Pharmacy Applications
Ernst, M. E. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1167 · Cited by 13
Endothelial function in postmenopausal women with nighttime systolic hypertension
Routledge, F. S., Hinderliter, A. L., McFetridge-Durdle, J., Blumenthal, J. A., Paine, N. J., & Sherwood, A. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000405 · Cited by 12
Ho, C. L. B., Chowdhury, E., Doust, J. A., Nelson, M. R., & Reid, C. M. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00469-1 · Cited by 11
Tan, J. S., Jaung, R., Gamble, G. D., & Cundy, T. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.023 · Cited by 10
“[30] Hermida RC, Ayala DE, Mojón A, Fernández JR.”
BackgroundHosomi, N., Sueda, Y., Masugata, H., Dobashi, H., Murao, K., Ueno, M., Miki, T., Kohno, M., Nishiyama, A., & Matsumoto, M. (2012) · Hypertension Research · doi:10.1038/hr.2012.25 · Cited by 10
Hypertension and Diabetic Nephropathy
Skov, J., Christiansen, J. S., & Poulsen, P. L. (2016) · Endocrine development · doi:10.1159/000439393 · Cited by 12
Park, S., Ihm, S., Cho, I., Kim, D., Park, J., Chung, W., Choi, S., Lee, H., Kim, H. C., Sohn, I. S., et al. (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00249-2 · Cited by 12
“4 years, bedtime dosing was associated with a 67% lower risk of total cardiovascular events and a 75% lower risk of major CVD events (CVD deaths, myocardial infarction (MI) and stroke) [6].”
BackgroundMethodAmbulatory Blood Pressure Monitoring: Killing the Elephant to Get Its Hair? No More, Please!
Portaluppi, F., Haus, E. L., & Smolensky, M. H. (2012) · Chronobiology International · doi:10.3109/07420528.2012.715841 · Cited by 10
“…outcome studies already available in international, peer-reviewed, widely read scientific journals controlled by major scientific and professional societies (Hermida et al., 2011a, 2011b, 2011c, 2012a, 2012b): another good reason for a presentation and discussion of them all in this special issue.”
BackgroundRuiz‐García, A., Arranz-Martínez, E., Merchante, I. M., Fuster, V. P., Tamarit, J. J., Trias, F., Pintó, X., & Ascaso, J. F. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.06.006 · Cited by 14
Update in Hypertension Therapy
Mankin, L. A. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.03.005 · Cited by 9
Aoki, T., Ohashi, N., Isobe, S., Ishigaki, S., Matsuyama, T., Sato, T., Fujikura, T., Kato, A., Miyajima, H., & Yasuda, H. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4243-19 · Cited by 9
“The change in administration time of antihypertensive drugs from morning to bedtime, namely chronotherapy, has recently been recommended to decrease the BP throughout the day, especially at night (13-15), and ameliorate CVD (16, 17) and renal damage (18).”
Chronotherapy in Hypertension: A Pill at Night Makes Things Right?
Orías, M., & Correa‐Rotter, R. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011101012 · Cited by 8
Are diabetes guidelines truly evidence based?
Bouchonville, M. F., Matani, S., DuBroff, J. J., & DuBroff, R. J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.035 · Cited by 8
Hermida, R. C., Moyá, A., & Ayala, D. E. (2015) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.03.012 · Cited by 10
Self-citationAnalysis of Recent Papers in Hypertension
Basile, J., & Bloch, M. J. (2012) · Journal of Clinical Hypertension · doi:10.1111/jch.12028 · Cited by 7
“A simple intervention of giving 1 of 3 antihypertensive agents at bedtime in these patients favorably reduces CV risk and improves dipping status in hypertensive patients with diabetes.(1)”
BackgroundPollak, P. T., Herman, R., & Feldman, R. D. (2017) · Clinical and Translational Science · doi:10.1111/cts.12442 · Cited by 7
Wirtwein, M., Melander, O., Sjögren, M., Hoffmann, M., Narkiewicz, K., Gruchała, M., & Sobiczewski, W. (2017) · Hypertension Research · doi:10.1038/hr.2017.87 · Cited by 8
Zhao, D., Liu, H., & Dong, P. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.07.031 · Cited by 7
Hermida, R. C. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2014.03.010 · Cited by 8
Self-citationMakowsky, M. J., Prebtani, A. P. H., Gelfer, M., Manohar, A., & Jones, C. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.09.002 · Cited by 8
Hanayama, Y., Uchida, H. A., Nakamura, Y., & Makino, H. (2012) · PubMed · doi:10.18926/amo/49041 · Cited by 7
“Elevated morning home blood pressure (MHBP) is a causative factor of mortality and morbidity by cardiovascular disease [14-17].”
BackgroundPresión arterial ambulatoria, cronoterapia de la hipertensión y glaucoma
Hermida, R. C., & Ayala, D. E. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.05.013 · Cited by 6
Self-citationPhysiological and pathophysiological role of the circadian clock system
Halmos, T., & Suba, I. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29436 · Cited by 6
Zhao, J., Zeng, Y., Weng, J., Zhang, J., Yao, T., Yuan, M., & Shen, X. (2022) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2022.102111 · Cited by 5
Chronotherapy of hypertension: current state of the problem and prospects
Kobalava, Z. D., & Троицкая, Е. А. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5395 · Cited by 8
Smolensky, M. H., Portaluppi, F., & Hermida, R. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-22771-9_6 · Cited by 7
Self-citationThe chronotherapy of hypertension: or the benefit of taking blood pressure tablets at bedtime
Vernon, G. (2017) · British Journal of General Practice · doi:10.3399/bjgp17x690269 · Cited by 6
Management of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 6
Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes
Friedman, E. A., & Banerji, M. A. (2011) · Diabetes Care · doi:10.2337/dc11-0576 · Cited by 5
“(5) prompts us to reexamine the basis for management of glycemia through the lens of chronobiology.”
BackgroundInfluentialHermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2011) · Diabetes Care · doi:10.2337/dc11-1611 · Cited by 4
“As such, our statements and conclusions on the different shape of the relationship with cardiovascular risk for achieved clinic blood pressure and asleep blood pressure mean seem adequate (2).”
InfluentialSelf-citationAmbulatory blood pressure, chronotherapy of hypertension and glaucoma
Hermida, R. C., & Ayala, D. E. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.04.043 · Cited by 4
Self-citationPerry, L. A., Surowiec, S., Danso, D., Kerobo, O., Anugwom, A., & Couvertier, K. (2019) · Journal of Contemporary Pharmacy Practice · doi:10.37901/jcphp18-00010 · Cited by 4
Theilade, S., Lajer, M., Joergensen, C., Persson, F., & Rossing, P. R. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00689.x · Cited by 4
“Treatment of nocturnal hypertension may be important and has been shown to reduce CVD mortality and morbidity in patients with type 2 diabetes.(36) In our study, ABP recordings with radial artery tonometry were successful in 98% of cases and overall well tolerated by patients, wherein 92% of patients found the discomf…”
BackgroundHjortkjær, H. Ø., Jensen, T. J., Kofoed, K. F., Mogensen, U. M., Køber, L., Hilsted, K. L., Corinth, H., Theilade, S., & Hilsted, J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006142 · Cited by 4
Ambulatory blood pressure monitoring in diabetes for the assessment and control of vascular risk
Hermida, R. C., Moyá, A., & Ayala, D. E. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.10.009 · Cited by 5
“On the other hand, the results of the MAPEC study, pending their potential confirmation by other prospective studies such as the currently ongoing Hygia Project, suggest (i) that decreasing mean resting BP and increasing dipping toward a higher dipper profile --two new therapeutic objectives that require the evaluatio…”
Self-citationControversies Among the Hypertension Guidelines
Ripley, T. L., & Baumert, M. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190015615879 · Cited by 4
“Several small studies published more recently have corroborated the efficacy of this alternative administration method, but, again, large RCTs are still lacking.(26,27) Highlights from this statement are summarized in Table 2.”
Rossen, N. B., & Hansen, K. W. (2011) · Diabetes Care · doi:10.2337/dc11-1514 · Cited by 5
“(1) have recently shown an impressive reduction of asleep blood pressure and associated reduction of cardiovascular disease (CVD) events in type 2 diabetic patients treated with at least one antihypertensive drug at bedtime compared with patients who ingested all drugs in the morning.”
Wang, F., Peng, Y., Yu, H., Gan, L., & Cao, Y. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168048 · Cited by 4
Ambulatory Blood Pressure Measurements in the Management of Hypertension: Practical Importance
Pakshirajan, B., & Sankaradas, A. M. (2015) · Hypertension Journal · doi:10.5005/jp-journals-10043-0003 · Cited by 3
Yadav, J., Khan, N., Das, R., & Mehta, D. K. (2025) · Current Hypertension Reviews · doi:10.2174/0115734021332079241226115916 · Cited by 3
Yoshinari, O., Udani, J. K., Moriyama, H., Shiojima, Y., & Chien, X. (2015) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v5i6.193 · Cited by 3
Hemmstoffe des Renin-Angiotensin-Systems
Weber, F., & Anlauf, M. (2017) · Springer eBooks · doi:10.1007/978-3-662-54630-7_8 · Cited by 3
Blood Pressure Monitoring in Cardiovascular Disease
Villalva, C. M., López-Alvarez, X. L. M., Rodríguez, M. M., Freire, M. J. M., Veloso, O. Q., Guede, L. C., Dosantos, S. V., Ramos, M. B., & 3 Nutricia. Madrid, S. (2017) · AIMS Medical Science · doi:10.3934/medsci.2017.2.164 · Cited by 3
“…monitoring of BP and cardiovascular events), a prospective single-centre study which investigated 3344 normotensive and hypertensive subjects [112,113], together with its substudies corresponding to diabetic [114] and kidney patients [115], showed that nocturnal administration of at least…”
Cronoterapia en hipertensión arterial
Bendersky, M. (2015) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2015.04.001 · Cited by 5
Chapter 5. Treatment with antihypertensive drugs
(2014) · Hypertension Research · doi:10.1038/hr.2014.8 · Cited by 6
Asleep blood pressure: relevance to the proper definition of isolated-office and masked hypertension
Hermida, R. C., Ayala, D. E., Smolensky, M. H., Mojón, A., Fernández, J. R., & Portaluppi, F. (2013) · Hypertension Research · doi:10.1038/hr.2012.225 · Cited by 3
Self-citationWrist-worn blood pressure tracking in healthy free-living individuals using neural networksPreprint
Radha, M., de Groot, K., Rajani, N. B., Wong, C. C. P., Kobold, N., Vos, V., Fonseca, P. M., Mastellos, N., Wark, P. A., Velthoven, N., et al. (2018) · arXiv (Cornell University) · Cited by 3
The mineralocorticoid receptor: a new chapter for therapeutic regulation of diabetic cardiomyopathy
Kanki, M., & Young, M. J. (2026) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2026.01.004 · Cited by 3
Pandya, N., & Patel, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-74720-6_38 · Cited by 2
Circadian rhythm in hypertension: Bibliometrics and knowledge mapping from 1990 to 2022
Peng, Z., Tan, Y., Zou, X., & Zhang, X. (2024) · Chronobiology International · doi:10.1080/07420528.2024.2362972 · Cited by 4
“In 2011, Hermida published a review showing that treatment with angiotensin receptor blockers at night can significantly decrease nocturnal BP. Individualized therapy was emphasized to control hypertension (Hermida et al. 2011).”
A call for wider use of ambulatory blood pressure monitoring in patients with diabetes
Eguchi, K. (2011) · Hypertension Research · doi:10.1038/hr.2011.123 · Cited by 2
Beltramello, G., Manicardi, V., Mazzuoli, F., & Rivellese, A. A. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0508-4 · Cited by 2
“Administer at least one of the antihypertensive medications at bedtime [25].”
BackgroundDo patients with obstructive sleep apnoea deserve new dedicated antihypertensive strategies?
Tamisier, R., Levy, P. A., & Pépin, J. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209772 · Cited by 3
Investigation and management of adult hypertension
Ng, F. L., & Lobo, M. D. (2018) · Heart · doi:10.1136/heartjnl-2017-311443 · Cited by 3
Haghayegh, S., Hermida, R. C., Smolensky, M. H., Gallardo, M. J., Duran-Aniotz, C. A., Slachevsky, A., Behrens, M. I., Aguillon, D. F., Santamaría‐García, H. A., García, A. M., et al. (2025) · Clocks & Sleep · doi:10.3390/clockssleep7010011 · Cited by 3
Self-citationLi, X., Zhang, R., Chen, X., Bao, S., & Jiang, H. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094100 · Cited by 1
Guo, Y., Wang, L., & Zhu, L. (2025) · European journal of medical research · doi:10.1186/s40001-025-03248-1 · Cited by 1
“This classification has been employed in numerous related studies to ensure result comparability [81, 82].”
Chronocardiology and cardiovascular health: a review of circadian rhythms in health and disease
Edpuganti, S., Sajeev, S. K., Nisa, A. N., Sunny, N. R., & Otim, M. L. (2026) · Cardiology Plus · doi:10.1097/cp9.0000000000000153 · Cited by 1
Taking blood pressure-lowering medications at night.
Turgeon, R. D., & Allan, G. M. (2012) · PubMed · Cited by 3
Nighttime Blood Pressure in Diabetes: Better Treat It Than Leave It
Tsioufis, C. P., Kasiakogias, A., Thomopoulos, C., & Stefanadis, C. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.236 · Cited by 2
Current Therapeutic Approaches to Cardio-Protection in Hypertension
Parra, D., & Hough, A. R. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0457-5 · Cited by 1
Nonglycemic Targets in Diabetes
DeWitt, D. E., Dugdale, D. C., & Adam, W. R. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.014 · Cited by 2
Management of Overt Diabetic Kidney Disease and Uremia
Schernthaner, G., & Prischl, F. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-08873-0_5 · Cited by 1
Hemmstoffe des Renin-Angiotensin-Systems
Anlauf, M., & Weber, F. (2016) · Springer eBooks · doi:10.1007/978-3-662-50351-5_8 · Cited by 1
Hemmstoffe des Renin-Angiotensin-Systems
Anlauf, M., & Weber, F. (2015) · Springer eBooks · doi:10.1007/978-3-662-47186-9_4 · Cited by 3
Хронотерапия артериальной гипертонии: современное состояние вопроса
Боев, С. С., Dotsenko, N. Y., Shekhunova, I. A., & Герасименко, Л. В. (2021) · HYPERTENSION · doi:10.22141/2224-1485.6.62.2018.153929 · Cited by 1
Blutdruckziele bei Patienten mit Diabetes mellitus: Was sind optimale Werte?
Dederer, J., Bewarder, Y., Mahfoud, F., & Böhm, M. (2019) · Herz · doi:10.1007/s00059-019-4796-5 · Cited by 1
Alicic, R. Z., & Tuttle, K. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42973-3.00037-8 · Cited by 1
Precision Medicine Approaches for Management of Type 2 Diabetes
Chen, D., Fulcher, J., SCOTT, E. S., & Jenkins, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_1 · Cited by 3
Blood pressure control in type 2 diabetes over time – what can we learn from different trajectories?
Nilsson, P. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000720 · Cited by 2
“Another way is to recommend bedtime intake of antihypertensive drugs as this has been shown to be effective in patients with type 2 diabetes, when either all [10] or some [11] of the daily antihypertensive drugs were taken at bedtime as an example of chronotherapy.”
BackgroundComorbidies of Blood Pressure and Blood Glucose: Challenges and Future TrendsPreprint
Ashisha, G. R., Mary, X. A., Karthik, C., & Gheisari, M. (2024) · Preprints.org · doi:10.20944/preprints202403.1154.v1
Hermida, R. C. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2014.03.003
Self-citationMohandas, R., & Ejaz, A. A. (2011) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed.2011.100345
La prise en charge de l’hypertension artérielle : vers une approche personnalisée du traitement
Poirier, L., & Moreau, P. R. (2012) · Pharmactuel
O efeito da cronoterapia no risco cardiovascular em doentes hipertensos: uma revisão sistemática
Fernandes, U. V. M. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/a9xf-e019 · Cited by 1
Hermida, R. C., Ayala, D. E., Smolensky, M. H., & Portaluppi, F. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3450-8_11
Self-citationPURLs: BP meds: this simple change improves outcomes.
Kirley, K., Sharma, U., & Rowland, K. (2012) · PubMed · Cited by 1
New diagnostics for hypertension in diabetes and the role of chronotherapy: a new perspective
Rossen, N. B., & Hansen, K. W. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000103
Tratamiento de la hipertensión arterial en la enfermedad renal crónica
Palomo‐Piñón, S., Rosas-Peralta, M., & Paniagua-Sierra, J. R. (2016) · Redalyc (Universidad Autónoma del Estado de México)
Mechanisms and Potential Therapy on Disrupted Blood Pressure Circadian Rhythm in Diabetes
Hou, T. (2018) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2018.464
Metadata
- Authors
- Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R.
- Affiliations
- Universidade de Vigo (ES)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-05-20
- Volume
- 34
- Issue
- 6
- Pages
- 1270-1276
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3114338
- OpenAlex
- W2141454310
- Cited by
- 213
- References
- 25
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 9 · 2022: 9 · 2021: 3 · 2020: 10 · 2019: 10 · 2018: 16 · 2017: 15 · 2016: 21 · 2015: 27 · 2014: 14 · 2013: 16 · 2012: 36
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- antihypertensive drugs, type 2 diabetes, hypertension, ambulatory blood pressure, nocturnal blood pressure, cardiovascular risk reduction, cardiovascular mortality, myocardial infarction, stroke, blood pressure control
- MeSH terms
- Adolescent, Aged, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Circadian Rhythm, Diabetes Mellitus, Type 2, Female, Humans, Hypertension, Male, Middle Aged, Risk, Blood Pressure Monitoring, Ambulatory, Drug Chronotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.